Phospholipase A2 in serum and colonic mucosa in ulcerative colitis

Author： Haapamäki M M Grönroos J M Nurmi H Irjala K Alanen K A Nevalainen T J

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.59, Iss.4, 1999-07, pp. : 279-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 4, 2015-08 ,pp. : 413-415

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of appendicectomy on colonic inflammation and neoplasia in experimental ulcerative colitis

BRITISH JOURNAL OF SURGERY, Vol. 103, Iss. 11, 2016-10 ,pp. : 1530-1538

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 386-398

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vedolizumab for ulcerative colitis and Crohn's disease

PRESCRIBER, Vol. 26, Iss. 10, 2015-05 ,pp. : 22-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel treatment options for ulcerative colitis

By Vaughn Byron P Moss Alan C

Clinical Investigation, Vol. 3, Iss. 11, 2013-11 ,pp. : 1057-1069

Future Science

Access to resources Recommend Favorite